<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03623659</url>
  </required_header>
  <id_info>
    <org_study_id>ALADDIN</org_study_id>
    <nct_id>NCT03623659</nct_id>
  </id_info>
  <brief_title>pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts</brief_title>
  <official_title>Does Partial Zona Pellucida Removal From Vitrified-warmed Human Blastocysts Improve Delivery Rate in IVF? A Multicentric RCT on Laser Assisted Hatching</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of study is to assess the possible impact of assisted hatching on delivery rate after
      transfer of vitrified-warmed human blastocysts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Zona pellucida (ZP) manipulation, termed &quot;assisted hatching&quot; (AH), has been introduced in
      order to favor embryo hatching and ultimately improve assisted reproductive technology
      success but with poor proofs of safety and biological plausibility.

      Vitrifying and warming of blastocysts may impair the successful hatching process of the
      embryo out of its ZP and its following implantation into the uterus. Theoretically, AH may
      facilitate the hatching process and subsequently increase implantation rates.

      In this prospective randomized controlled trial (RCT), the hypothesis is to test whether the
      application of a partial AH to vitrified/warmed blastocysts might affect patients' delivery
      rate.

      Patients with vitrified blastocysts will be randomized at the time of blastocyst warming to a
      study group (with AH) or a control group (without AH). AH will be performed at the expanded
      blastocyst stage using a laser technique and a laser opening will be initiated at the 1
      o'clock position. Consecutive laser shots will be applied to reach the 5 o'clock position of
      the blastocyst. The blastocysts will then be cultured at least 2 h and subsequently
      transferred into the patient's uterus.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Delivery rate</measure>
    <time_frame>38 weeks after embryo transfer</time_frame>
    <description>Number of deliveries, that result in a live birth, per transferred blastocyst</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>6-7 weeks after transfer</time_frame>
    <description>the number of gestational sacs observed at echographic screening at 6 weeks of pregnancy divided by the number of transferred embryos</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Pregnancy rate</measure>
    <time_frame>4 weeks after transfer</time_frame>
    <description>the ultrasonographic demonstration of an intrauterine gestational sac divided by the number of included women</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemical pregnancy rate</measure>
    <time_frame>4 week after transfer</time_frame>
    <description>Pregnancies failing to progress to the point of ultrasound confirmation divided by the number of women with a positive pregnancy test on blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rate</measure>
    <time_frame>20 weeks after transfer</time_frame>
    <description>the ultrasonographic demonstration of an intrauterine gestational sac with fetal hearth divided by the number of included women</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multiple pregnancy rate</measure>
    <time_frame>4 week after transfer</time_frame>
    <description>a pregnancy in which more than one fetus develops in the uterus at the same time divided by the number of women with a clinical pregnancy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>obstetrical and neonatal complication rate</measure>
    <time_frame>after birth; 9-10 months after transfer</time_frame>
    <description>condition that adversely affects women and their foetal health during delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>congenital anomalies rate</measure>
    <time_frame>after birth, 9-10 months after transfer</time_frame>
    <description>birth defects, congenital disorders, congenital malformations, or congenital abnormalities, are conditions of prenatal origin that are present at birth, potentially impacting an infant's health, development and/or survival divided by the number of livebirths</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>AH group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects whose vitrified/warmed blastocysts will be subjected to the treatment of laser assisted hatching</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects whose vitrified/warmed blastocysts will be subjected to the same procedures except for the treatment of laser assisted hatching</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser assisted hatching</intervention_name>
    <description>After warming, blastocysts are subjected to laser assisted hatching (LAH) following the standard procedure.The LAH procedure lasts one minute per blastocyst.</description>
    <arm_group_label>AH group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  single embryo transfer of vitrified/warmed blastocyst (SET)

          -  first or second frozen IVF (with or without Intracytoplasmic Sperm Injection) cycle of
             blastocysts

          -  first or second oocyte retrieval

        Exclusion Criteria:

          -  Preimplantation Genetic Testing (PGT) cycle

          -  BMI &gt; 35 kg/m2

          -  severe male factor

          -  abnormal uterine cavity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessandra Alteri, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS San Raffaele</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alessandra Alteri, PhD</last_name>
    <phone>+390226434308</phone>
    <email>alteri.alessandra@hsr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Paola Vigano', PhD</last_name>
    <phone>+390226436228</phone>
    <email>vigano.paola@hsr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liliana Restelli</last_name>
      <email>liliana.restelli@policlinico.mi.it</email>
    </contact>
    <contact_backup>
      <last_name>Cristina Guarneri</last_name>
      <email>cristina.guarneri@policlinico.mi.it</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Alteri, PhD</last_name>
      <phone>+390226434308</phone>
      <email>alteri.alessandra@hsr.it</email>
    </contact>
    <contact_backup>
      <last_name>Paola Vigano', PhD</last_name>
      <phone>+390226436228</phone>
      <email>vigano.paola@hsr.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Alteri A, Vigan√≤ P, Maizar AA, Jovine L, Giacomini E, Rubino P. Revisiting embryo assisted hatching approaches: a systematic review of the current protocols. J Assist Reprod Genet. 2018 Mar;35(3):367-391. doi: 10.1007/s10815-018-1118-4. Epub 2018 Jan 19.</citation>
    <PMID>29350315</PMID>
  </reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>August 3, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <last_update_submitted>December 20, 2018</last_update_submitted>
  <last_update_submitted_qc>December 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Alessandra Alteri</investigator_full_name>
    <investigator_title>Principal Investigator, PhD</investigator_title>
  </responsible_party>
  <keyword>Assisted hatching</keyword>
  <keyword>Zona pellucida</keyword>
  <keyword>Implantation failure</keyword>
  <keyword>Blastocyst</keyword>
  <keyword>Cryopreservation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

